Skip to main content

ALGS

Aligos Therapeutics, Inc.

Company with tickers: ALGS

CIK
1799448
CUSIP
01626L204
Shares Outstanding
5,388,223
13F Activity (30d)
29 filings 27 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 34
Total Value: $20,618,871
Total Shares: 2,775,086

Institutional Ownership Trend

7 quarters

Holder Concentration

Across 34 13F filers · Δ vs Dec 31, 2025
Top Holder
16.0%
Sep 2024 → Mar 2026 · range 14.1% – 31.4%
+0.2 pts
Top 5
60.5%
Sep 2024 → Mar 2026 · range 57.0% – 77.6%
−1.7 pts
Top 10
85.3%
Sep 2024 → Mar 2026 · range 83.0% – 95.5%
+2.1 pts
HHI
933
Sep 2024 → Mar 2026 · range 851 – 1,658
Broadly held−2

Quarterly Activity

vs Dec 31, 2025
New
6
Increased
8
Decreased
9
Sold Out
12
Unchanged
11
Holder count: -6
Institutional value: -21.3%
Shares held: -1.3%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 34 of 34
Export CSV
Holder Value (USD) % of 13F Shares Open